An Overview of Hepatitis B Virus Surface Antigen Secretion Inhibitors

Current anti-hepatitis B virus (HBV) regimen do not meet ideal result due to emerging resistance strains, cytotoxicity, and unfavorable adverse effects. In chronic HBV infection, high rates of sub-viral particles (SVPs) bearing HBV surface antigen (HBsAg) is a major obstacle regarding to raise effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohebbi, Alireza, Lorestani, Nazanin, Tahamtan, Alireza, Kargar, Niki L., Tabarraei, Alijan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895781/
https://www.ncbi.nlm.nih.gov/pubmed/29675010
http://dx.doi.org/10.3389/fmicb.2018.00662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895781/
https://www.ncbi.nlm.nih.gov/pubmed/29675010
http://dx.doi.org/10.3389/fmicb.2018.00662

Ejemplares similares